Teens with severe alopecia areata: treatment safety study
Part of Skin clinical trials.
This study tracks the safety and effectiveness of alopecia areata treatments in teenagers aged 12-17. It helps doctors understand which treatments work best and are safest for young people with severe hair loss.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 12 and 17 years old.
- A dermatologist has said you have severe alopecia areata.
- You agree to take part in the study.
- You are not in a study where you don't know which treatment you're getting.
- You can provide your height measurement.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry collects information from adults with alopecia areata who are starting or taking certain approved medications. It helps researchers understand how well these treatments work and how safe they are in real-world care.
This trial tests an experimental oral tablet (VC005) in teenagers with severe alopecia areata, a condition that causes patchy hair loss. The goal is to see if the drug is safe and may help regrow hair.
This study tests an investigational drug to see if it can help people with severe alopecia areata, a condition that causes hair loss. It may help regrow hair.
This trial tests a new drug called FB102 for people with severe to very severe alopecia areata, a condition that causes at least half of scalp hair to be lost. It aims to see if the drug is safe and can help hair grow back.
This study tests an oral tablet called upadacitinib for people with severe alopecia areata who have lost at least half of their scalp hair. It aims to see if the drug can safely help hair regrow.
This trial is a registry that collects information from people with alopecia areata who are starting or using body-wide treatments. It helps doctors learn more about how these treatments work in real life.
Hear when a new Alopecia Areata trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.